(1)
Simvastatin Treatment Reduces the Cholesterol Content of Membrane Lipid Rafts, Implicating the N -Methyl-D-Aspartate Receptor in Anxiety: A Literature Review. Braz. J. Pharm. Sci. 2017, 53 (1), e16102-. https://doi.org/10.1590/s2175-97902017000116102.